Evidence map›Paper›PMID 39599848›Full record

ArticleViruses2024

Impact of Different Foot and Mouth Disease Vaccine Schemes in Cross-Neutralization Against Heterologous Serotype O Strains in Cattle.

María Cruz Miraglia, Melanie Barrios-Benito, Sabrina Galdo-Novo, Danilo Bucafusco, Ana Taffarel, Alejandra Victoria Capozzo, Manuel Victor Borca, Daniel Mariano Pérez-Filgueira

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

María Cruz MiragliaInstituto de Virología e Innovaciones Tecnológicas, CICVyA, INTA-CONICET, Buenos Aires 1686, Argentina.
Melanie Barrios-BenitoWOAH FMD Reference Laboratory, SENASA, Buenos Aires 1640, Argentina.
Sabrina Galdo-NovoWOAH FMD Reference Laboratory, SENASA, Buenos Aires 1640, Argentina.ORCID 0000-0003-0678-5294
Danilo BucafuscoCátedra de Virología, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires (UBA), Buenos Aires 1427, Argentina.ORCID 0000-0002-2844-7475
Ana TaffarelInstituto de Virología e Innovaciones Tecnológicas, CICVyA, INTA-CONICET, Buenos Aires 1686, Argentina.
Alejandra Victoria CapozzoCentro de Altos Estudios en Ciencias Humanas y de la Salud, CONICET-Universidad Abierta Interamericana, Av. Montes de Oca 745, Buenos Aires 1270, Argentina.
Manuel Victor BorcaPlum Island Animal Disease Center, ARS, USDA, Greenport, NY 11944, USA.
Daniel Mariano Pérez-FilgueiraInstituto de Virología e Innovaciones Tecnológicas, CICVyA, INTA-CONICET, Buenos Aires 1686, Argentina.ORCID 0000-0002-0111-5358

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2021-0953Instituto Nacional de Tecnología Agropecuaria PD-I-113United States Department of Agriculture G-202302-69885
6 · The paper itself

Abstract

The high antigenic variability of the foot-and-mouth disease virus (FMDV) represents a challenge for developing prophylactic strategies, stressing the need for research into vaccines offering broad protection against a range of virus strains. Here, the heterotypic cross-reaction using different vaccine schemes against serotype O strains was studied, evaluating the impact of revaccination, antigen dose, and incorporation of additional FMDV serotypes. Naïve cattle were immunized with seven distinct FMDV vaccines, receiving three doses of the same formulation at 0, 28, and 56 days post-primary vaccination (dpv). Serum samples were collected up to 70 dpv and tested by a virus-neutralizing test against serotype O strains from a South American lineage and two strains representative of two Asian lineages. Our results showed that vaccines containing the ME-SA topotype O1/Campos strain developed cross-neutralizing responses against the two Asian viruses after the first vaccination. In contrast, significant heterotypic neutralizing antibody titers against the homologous topotype strain were only found after the second vaccination, indicating that the phylogenic relationship may differ from the antigenic profiles for these two viruses. The amount of the O1/Campos strain and the revaccination were essential factors for neutralization against the homologous- and heterologous-type O FMDV viruses. The strain composition of the vaccine was only relevant for cross-neutralization against one of the Asian strains, suggesting potential intra-serotypic divergences for this pattern.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCattle DiseasesCross ReactionsFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusSerogroupVaccinationViral VaccinesAnimalsCattleCross ProtectionNeutralization TestsPhylogenyAntibodies, NeutralizingAntibodies, ViralViral Vaccinescattlefoot-and-mouth diseaseheterologous protection

Identifiers

PMID39599848
PMCPMC11599131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.